HSV Based Virotherapy Market Size

Herpes Simplex Virus Treatment Market size was over USD 2.64 billion in 2023 and is projected to exceed USD 6.92 billion by 2036, witnessing over 7.7% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of herpes simplex virus treatment is assessed at USD 2.8 billion.

The growth of the market can be attributed to the growing prevalence of rare kinds of cancer, and the growing demand for better and more effective treatments for cancer. According to the data by the World Health Organization (WHO), cancer is the second leading cause of death and caused over 10 million deaths in 2020. The virotherapy is a new approach for treatment of various diseases which do not have any existing cures. In Herpes simplex virus treatment, herpes simplex virus is mutated in a controlled environment and is used to destroy the cancerous cells in the patient’s body. Moreover, increasing research and development in medical science, along with mounting investment by major pharmaceutical companies to develop new treatment approach, is estimated to boost the market growth.